BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2882787)

  • 1. Neuroleptic-induced parkinsonism in older schizophrenics.
    Hoffman WF; Labs SM; Casey DE
    Biol Psychiatry; 1987 Apr; 22(4):427-39. PubMed ID: 2882787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-year follow-up of older schizophrenics: extrapyramidal syndromes, psychiatric symptoms, and ventricular brain ratio.
    Hoffman WF; Ballard L; Turner EH; Casey DE
    Biol Psychiatry; 1991 Nov; 30(9):913-26. PubMed ID: 1684118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The psychological consequences of tardive dyskinesia. The effect of drug-induced parkinsonism and the topography of the dyskinetic movements.
    Brown KW; White T
    Br J Psychiatry; 1991 Sep; 159():399-403. PubMed ID: 1683594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tardive dyskinesia: neuropsychological, computerized tomographic, and psychiatric symptom findings.
    Gold JM; Egan MF; Kirch DG; Goldberg TE; Daniel DG; Bigelow LB; Wyatt RJ
    Biol Psychiatry; 1991 Sep; 30(6):587-99. PubMed ID: 1681948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced parkinsonism: relationship to age at onset of schizophrenia.
    Sandyk R; Kay SR
    Funct Neurol; 1991; 6(2):151-7. PubMed ID: 1680777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics.
    Prosser ES; Csernansky JG; Kaplan J; Thiemann S; Becker TJ; Hollister LE
    J Nerv Ment Dis; 1987 Feb; 175(2):100-5. PubMed ID: 2879880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Negative symptoms, tardive dyskinesia and depression in chronic schizophrenia.
    Barnes TR; Liddle PF; Curson DA; Patel M
    Br J Psychiatry Suppl; 1989 Nov; (7):99-103. PubMed ID: 2575915
    [No Abstract]   [Full Text] [Related]  

  • 8. Tardive dyskinesia and positive symptoms of schizophrenia.
    White T; Brown KW; Woods JP
    Acta Psychiatr Scand; 1991 May; 83(5):377-9. PubMed ID: 1677232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tardive dyskinesia and dementia.
    Famuyiwa OO; Eccleston D; Donaldson AA; Garside RF
    Br J Psychiatry; 1979 Dec; 135():500-4. PubMed ID: 43754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.
    Brown KW; White T
    Biol Psychiatry; 1991 Dec; 30(12):1182-90. PubMed ID: 1686411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical findings in the cerebrospinal fluid of schizophrenic patients with tardive dyskinesia and neuroleptic-induced parkinsonism.
    Saito T; Ishizawa H; Tsuchiya F; Ozawa H; Takahata N
    Jpn J Psychiatry Neurol; 1986 Jun; 40(2):189-94. PubMed ID: 2431183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The influence of topography on the cognitive and psychopathological effects of tardive dyskinesia.
    Brown KW; White T
    Am J Psychiatry; 1992 Oct; 149(10):1385-9. PubMed ID: 1356314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of correlations among tardive dyskinesia, drug-induced parkinsonism, and psychosis.
    Hansen TE; Weigel RM; Brown WL; Hoffman WF; Casey DE
    J Neuropsychiatry Clin Neurosci; 1992; 4(1):29-35. PubMed ID: 1352714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive therapy in neuroleptic-induced parkinsonism.
    Goswami U; Dutta S; Kuruvilla K; Papp E; Perenyi A
    Biol Psychiatry; 1989 Jul; 26(3):234-8. PubMed ID: 2568133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive dysfunction in schizophrenia: organic vulnerability factor or state marker for tardive dyskinesia?
    Waddington JL; O'Callaghan E; Larkin C; Kinsella A
    Brain Cogn; 1993 Sep; 23(1):56-70. PubMed ID: 8105822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between negative symptoms in chronic schizophrenia and neuroleptic dose, plasma levels and side effects.
    Tugg LA; Desai D; Prendergast P; Remington G; Reed K; Zipursky RB
    Schizophr Res; 1997 May; 25(1):71-8. PubMed ID: 9176929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Instrumental motor predictors of neuroleptic-induced parkinsonism in newly medicated schizophrenia patients.
    Caligiuri MP; Lohr JB
    J Neuropsychiatry Clin Neurosci; 1997; 9(4):562-7. PubMed ID: 9447497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Schizophrenic deficit syndrome and neurologic tolerance].
    Verdoux H; Bourgeois M
    Encephale; 1996 Jun; 22 Spec No 2():45-7. PubMed ID: 8767042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cigarette smoking and neuroleptic-induced parkinsonism.
    Decina P; Caracci G; Sandik R; Berman W; Mukherjee S; Scapicchio P
    Biol Psychiatry; 1990 Sep; 28(6):502-8. PubMed ID: 1977478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.